Tag: Magictouch

Concept

ANVISA Grants Commercial Approval to Concept Medical’s MagicTouch Sirolimus-Coated Balloon for CAD in Brazil

up18news

Revolutionary ANVISA Approval Advances Cardiovascular Treatment in Brazil with Concept Medical’s MagicTouch São Paulo (Brazil), September 17:  Concept Medical Group, a global leader in drug-delivery technologies, announced that ANVISA (Agência Nacional de Vigilância Sanitária), Brazil’s Health Surveillance Agency, has granted commercial approval for its flagship MagicTouch, Sirolimus-Coated Balloon (SCB) for CAD treatment. This milestone enables patients […]

Continue Reading
MagicTouch - PNN

MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation

up18news

MagicTouch Receives Groundbreaking ANVISA Approval for Coronary Treatment in Brazil São Paulo (Brazil), September 17: The Brazilian health sector has just experienced a turning point with the MagicTouch Brazil Approval from ANVISA, the health surveillance national authority. Concept Medical Group, the drug-delivery technology market leader, has obtained commercial approval for its lead Sirolimus-Coated Balloon (SCB) […]

Continue Reading

Concept Medical Receives Third US FDA’s IDE Approval for Its Magictouch – Sirolimus Coated Balloon in Small Vessel Indication

up18news

Surat (Gujarat) [India], May 1: Concept Medical Inc. (CMI), a global leader in drug delivery devices, has received its third Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its novel Sirolimus-coated balloon, Magic Touch SCB, for the treatment of Small Vessels (SV) in coronary arteries. This milestone comes after […]

Continue Reading